Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial – a prospective pilot study

By de Bie Mihaly K.   Lekkerkerker Jaco C.   van Dam Bastiaan   Gaasbeek Andre   van Buren Marjolijn   Putter Hein   van Erven Lieselot   Bax Jeroen J.   Schalij Martin J.   Rabelink Ton J.   Jukema J. Wouter  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2151-2157

Informa Healthcare

Access to resources Recommend Favorite

Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada

By Deniz H. Baris   Ward Alexandra   Jaime Caro J.   Alvarez Piedad   Sadri Hamid  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 617-626

Informa Healthcare

Access to resources Recommend Favorite

Risk stratification for the primary prevention of arrhythmic sudden cardiac death in postinfarction patients

By  

Continuing Cardiology Education, Vol. 2, Iss. 3, 2016-09 ,pp. : 135-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Visualizing Risk for and Optimizing Prevention of Sudden Cardiac Death

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 11, 2015-11 ,pp. : 1247-1249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Substrate‐Based Ablation of Ventricular Tachycardia on Cardiac Mortality in Patients With Implantable Cardioverter‐Defibrillators

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 11, 2015-11 ,pp. : 1230-1238

John Wiley & Sons Inc

Access to resources Recommend Favorite